Investment Type: Venture Capital
Investment Stage: Seed
Portfolio 4
| Date | Name | Website | Total Raised | Location |
| 30.11.2022 | DayTwo | daytwo.com | $122M | United Sta... |
| 24.04.2022 | PharmAssis... | apowiser.c... | $1.5M | - |
| - | Karie, Pow... | aceage.com | $2M | Canada, On... |
| - | Sight Diag... | sightdx.co... | $99.24M | Israel, Te... |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | David | Gordon | Head of In... | linkedin.c... | - | d****g@lon... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 21.06.2022 | Apowiser Raises $1.5M In Seed Funding from Longliv Ventures,... | RA'ANANA, Israel, June 21, 2022 /PRNewswire/ -- Apowiser, an early-stage Israeli start-up that has d... | en.prnasia... |
| 05.08.2020 | Sight Diagnostics raises another $71M to fully commercialize... | “We have a specific focus on the U.S market and are planning to ramp up commercialization as allowed... | medcitynew... |
| 05.08.2020 | Sight Diagnostics raises $71M Series D for its blood analyze... | Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, t... | techcrunch... |
| - | Sight Diagnostics raises another $71M to fully commercialize... | Tel Aviv, Israel-based Sight Diagnostics, which makes a complete blood count (CBC) analyzer only req... | medcitynew... |